Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21281434 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4
Condition: Hepatitis C
Interventions: Drug: Pegylated interferon alpha 2a;   Drug: Ribavirin;   Drug: Pegylated interferon alpha 2 b plus ribavirin

Indicates status has not been verified in more than two years